June 11th 2025
Compared with penicillin, investigators reported no significant differences in the incidence of ophthalmologic manifestations among patients treated with ceftriaxone.
Eye Care Symposia in Los Angeles
April 25-26, 2025
Register Now!
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (CME Track)
View More
Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (CME Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (CME Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (COPE Track)
View More
Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (COPE Track)
View More
Surv.AI Says: Real-World Insights Into Patient Burden & Evolving Strategies in nAMD and DME (CME Credit)
View More
Surv.AI Says: Real-World Insights into Patient Burden & Evolving Strategies in nAMD and DME (COPE Credit)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (CME Track)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (COPE Track)
View More
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (COPE Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (CME Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (COPE Track)
View More
19th Annual Controversies in Modern Eye Care
May 4, 2025
Register Now!
(CME Track) Community Practice Connections™: Advancing the Optimal Diagnosis & Treatment of Thyroid Eye Disease
View More
(COPE Track) Community Practice Connections™: Advancing the Optimal Diagnosis & Treatment of Thyroid Eye Disease
View More
(CME) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Outlining the New Standard in Geographic Atrophy: Optimizing Care Within the Modern Treatment Paradigm (CME Track)
View More
Outlining the New Standard in Geographic Atrophy: Optimizing Care Within the Modern Treatment Paradigm (COPE Track)
View More
Collaborative Care Symposium
May 30-31, 2025
Register Now!
Community Practice Connections™: Novel Therapies for Neovascular Retinal Disease – Expert Analysis of New Key Data
View More
Practical Approaches to Modern Dry Eye Treatment and Management
June 25, 2025
Register Now!
Latest Advances in X-Linked Retinitis Pigmentosa: Optimizing Diagnosis and Developments in Gene Therapy
View More
Cases & Conversations™: Real World Review of Treat and Extend Strategies for Neovascular Retinal Disease
View More
Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (CME Track)
View More
Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (COPE Track)
View More
Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (CME Track)
View More
Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (COPE Track)
View More
Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (CME Credit)
View More
Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (COPE Credit)
View More
ARVO 2004 Retina presentations
April 1st 2004Among the 233 sessions dedicated to retina, almost 75 are free papersand symposia sessions. The Editorial Advisory Board of OphthalmologyTimes reviewed the retina abstracts to be presented at this year's meeting.Some of the board's selections are highlighted here.
Read More
Part-, full-time patching equally effective for severe amblyopia
April 1st 2004Rochester, MN-In young children with severe amblyopia, 6 hours of prescribed patching per day appears to be as effective as full-time prescribed patching when both are combined with 1 hour of near activity, according to the recently published results of the Amblyopia Treatment Study of patching regimens for severe amblyopia.
Read More
Research into deprivation amblyopia spawns wealth of information, greater understanding
April 1st 2004Morgantown, WV-Amblyopia due to stimulus deprivation differs from other forms of amblyopia in several ways. Research relating to deprivation amblyopia has resulted in increased understanding of the anatomic changes of amblyopia, guidance for treatment of amblyopia in general, and an improved definition of the concept of a critical period of visual development, said Terry L. Schwartz, MD.
Read More
Used properly, systemic medications effective in uveitis
April 1st 2004Baltimore-The use of systemic medications in uveitis therapy often is associated with superior outcomes, and the best results are likely when physicians adhere to proper dosing techniques and closely monitor patients for side effects, said Douglas A. Jabs, MD, MBA.
Read More
Angiogenesis plays role in ophthalmic diseases
April 1st 2004Editor's Note: Due to the large volume of information presented at the Angiogenesis 2004 meeting, this article is an overview of many of the presentations. Ophthalmology Times will provide greater detail of many of the sessions in upcoming issues.
Read More
Find out what's hot in frames to add to your inventory
March 15th 2004At this time many of you will be attending or about to attend the American Association of Dispensing Ophthalmologists (AADO) 10th Dispensing Ophthalmology Conference March 25 to 28 at International Vision Expo East, New York. Your participation in the largest optical and educational show can be even more beneficial if you take the time to prepare in advance.
Read More
Post-LASIK infection mandates prompt action
March 1st 2004Anaheim, CA-Infection after LASIK is uncommon, but when it happens, the consequences can be devastating, said Eduardo C. Alfonso, MD, at the International Society of Refractive Surgery/American Academy of Ophthalmology subspecialty day meeting.
Read More
Adding an optical dispensary to an existing ophthalmology practice can be a profitable and exciting venture, but one that must be organized carefully and executed deliberately. Ophthalmologists must plan-from the dispensary's inception to construction-exactly where everything will be and how it will appear to their patients.
Read More
Refractive surgery advances mean life-long gains
February 15th 2004Anaheim, CA-Surgeons and patients often consider refractive surgery to be a one-time intervention. A patient may have had RK or LASIK and possibly an enhancement, but then the doctor-patient relationship ended. This is no longer the case, nor should it be, explained George O. Waring III, MD, who delivered the keynote speech on refractive re-treatments during the International Society of Refractive Surgery/American Academy of Ophthalmology subspecialty day meeting.
Read More
Description of hay fever dates to as early as mid-1500s
February 15th 2004Editor's Note: In 1896 Alexander Duane, MD, author of the Student's Medical Dictionary, defined hay fever, otherwise known as hay asthma, as "a violent acute inflammation or congestion of the conjunctiva, nasal and bronchial mucous membranes, recurring at about the same time every spring or summer in those predisposed to it. It is apparently caused by inhalation of the pollen of certain plants and relieved by migration to a locality where the pollen is not found." This definition is concise and still valid today. The history of ocular allergy, and hay fever in particular, is rich and interesting, with astute
Read More
Lens designers and manufacturers are constantly searching for the perfect progressive addition lens. They strive to design the most comfortable lens both optically and cosmetically. This combination of both equals a lens that is thin, light, and versatile for all lifestyle activities, while delivering the sharpest visual acuity possible without noticeable power shifts in every meridian. Ophthalmic professionals don't have to wait for tomorrow for this technologically advanced progressive lens. It's here today.
Read More
Educational materials offered for patients, staff
December 15th 2003Jacksonville, FL-VISTAKON, a division of Johnson & Johnson Vision Care Inc., is offering an array of educational materials to help eye-care professionals instruct patients about eye health and run their practices more efficiently.
Read More
Pediatric uveitis: a diagnostic dilemma
November 1st 2003Editor's Note: Although less common than uveitis in adults, uveitis in children can present unique diagnostic and therapeutic challenges. Emmett T. Cunningham Jr., MD, PhD, MPH, editor of the "Uveitis Update" column in Ophthalmology Times, asked a panel of uveitis specialists to comment on various aspects of the condition in this roundtable discussion. Their comments have been edited for length and clarity.
Read More
Mindset change brings eye doctors around to dispensing
October 15th 2003In the past, ophthalmologists have had the luxury of viewing themselves as specialized surgical and medical care providers and have not been driven to include a retail profit center, such as an optical dispensary, in their practice.
Read More
For ophthalmologists who have decided to add an optical dispensary to their offices, the process of designing and equipping the space can be a daunting experience. Far more than just attaching frame display racks to the walls, the optical dispensary should be coordinated and blended with the decor and design of the rest of the office. It should also be designed for maximum efficiency and represent the doctors' aesthetic tastes.
Read More
Cyclosporine drops useful in topical steroid-resistant eyes
September 1st 2003Fort Lauderdale, FL-Cyclosporine A drops may be an effective treatment for Thygeson's superficial punctate keratitis (SPK) over the long term. It is especially useful in patients whose disease does not respond to treatment with steroids or those whose disease responds to steroids and who have elevated IOP levels, according to the results of a U.K. study reported at the Association for Research in Vision and Ophthalmology.
Read More
Topical drop handles moderate inflammation associated with KCS
August 15th 2003Fort Lauderdale, FL-Topical loteprednol etabonate 0.5% (Lotemax, Bausch & Lomb) instilled four times daily may be beneficial to treat patients who have keratoconjunctivitis sicca (KCS) with at least a moderate inflammatory component.
Read More
Alcon joins council to stress need for child eye exams
August 15th 2003Fort Worth, TX-Alcon Inc. is teaming with the Vision Council of America (VCA) to stress the importance of eye exams for school-age children as part of the "Check Yearly. See Clearly" national vision health awareness initiative.
Read More